Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing–remitting multiple sclerosis
Authors:
- 20 March 2019
- journal article
- letter
- Published by Springer Nature in Journal of Neurology
- Vol. 266 (6) , 1539-1540
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Application of OCT-angiography to characterise the evolution of chorioretinal lesions in acute posterior multifocal placoid pigment epitheliopathyEye, 2017
- Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosisTherapeutics and Clinical Risk Management, 2017
- Neurological Manifestations of Acute Posterior Multifocal Placoid Pigment EpitheliopathyJournal of Clinical Neurology, 2016
- Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Acute Posterior Multifocal Placoid Pigment EpitheliopathyArchives of Ophthalmology (1950), 1968